evidence. Limited Evidence A pair of studies suggested Provenge may slow by one to two weeks the progression of prostate cancer in men who have cancer that does not respond to hormone treatment.
Men who used the treatment also showed some evidence of living longer than those who took a placebo. In one trial, men who got active treatment lived an average of 3.3 months longer. In another, they lived four and a half months longer.
Hey idiot! The point is that the ONLY approved treatment, as of now, taxotere, for advanced terminal prostate cancer, does no better than provenge but has horrible side-effects, which provenge does not have! So, Provenge does not need to improve length of life by any large amount, it only needs to improve quality of life over Taxotere, which it DOES!!